Mounjaro Flexpen 2.5 (Tirzepatide SOLUTION) 2.5mg

Mounjaro Flexpen 2.5 delivers tirzepatide in a prefilled pen for convenient diabetes management. This GLP-1/GIP receptor agonist supports blood sugar control with once-weekly dosing. Ideal for adults with type 2 diabetes seeking flexible treatment options.

Strength

2.5mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Lilly

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tirzepatide, the active ingredient in Mounjaro Flexpen 2.5, is prescribed to improve blood sugar levels in adults with type 2 diabetes. It works alongside diet and exercise to support glycemic control. People often ask, what is tirzepatide used for, and it is primarily used for diabetes management rather than weight loss alone.

Side Effects

Users may notice improved blood sugar stability within weeks of starting tirzepatide. Common effects include reduced appetite and gradual weight stabilization. The solution is designed for subcutaneous injection, which may cause mild site reactions like redness or itching.

Precautions & Warnings

Store Mounjaro Flexpen 2.5 refrigerated between 2–8°C and protect from light. Avoid freezing or shaking the pen vigorously. Keep out of reach of children and pets. Discard the pen after 28 days of first use, even if solution remains.

Avoid Interactions

Alcohol may affect blood sugar levels when combined with tirzepatide. Other diabetes medications, such as insulin or sulfonylureas, may require dose adjustments. Always inform your healthcare provider about all medications, including over-the-counter drugs and supplements, before starting tirzepatide.

Frequently Asked Questions

The pen is designed for subcutaneous injection once weekly. Follow the patient instructions provided with the product.

Tirzepatide is available by prescription only. Consult a healthcare provider to determine if it is appropriate for your condition.

Common effects may include nausea, diarrhea, or mild injection-site reactions. These effects are usually temporary.

Mounjaro Flexpen 2.5 is prescribed for type 2 diabetes management. Weight loss may occur as a secondary effect but is not its primary purpose.

Blood sugar improvements may be noticed within a few weeks, but individual results vary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.